Fermata Advisors’s Innovator US Equity Ultra Buffer ETF January UJAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-59,805
Closed -$2.42M 232
2025
Q2
$2.42M Sell
59,805
-438,848
-88% -$17M 0.65% 47
2025
Q1
$19M Sell
498,653
-41,567
-8% -$1.62M 3.44% 2
2024
Q4
$21M Sell
540,220
-19,723
-4% -$760K 3.93% 4
2024
Q3
$21.3M Buy
559,943
+23,805
+4% +$892K 4.33% 3
2024
Q2
$19.9M Buy
536,138
+38,703
+8% +$1.4M 4.57% 3
2024
Q1
$18M Buy
+497,435
New +$17.5M 4.05% 3
2022
Q4
Sell
-12,565
Closed -$367K 147
2022
Q3
$367K Sell
12,565
-7,125
-36% -$210K 0.12% 105
2022
Q2
$573K Sell
19,690
-7,466
-27% -$223K 0.2% 93
2022
Q1
$840K Buy
27,156
+15,571
+134% +$479K 0.31% 71
2021
Q4
$366K Sell
11,585
-108
-0.9% -$3.4K 0.13% 112
2021
Q3
$364K Sell
11,693
-8,862
-43% -$276K 0.16% 105
2021
Q2
$637K Sell
20,555
-28,919
-58% -$890K 0.37% 60
2021
Q1
$1.5M Buy
+49,474
New +$1.49M 1.26% 20

Other funds holding UJAN

Fermata Advisors's UJAN Position: Q3 2025 in Review

Fermata Advisors sold out of Innovator US Equity Ultra Buffer ETF January (UJAN) in Q3 2025, closing a stake of 59,805 shares — an estimated $2.42M sold.

Fermata Advisors first reported a position in UJAN in Q1 2021 and held it in 13 quarters. The position peaked at $21.3M in Q3 2024. 96 funds tracked by Wall St. Rank hold UJAN as of Q3 2025.

  • Fermata Advisors reported no remaining Innovator US Equity Ultra Buffer ETF January position as of Q3 2025 after selling out during the quarter.
  • Fermata Advisors sold 59,805 Innovator US Equity Ultra Buffer ETF January shares in Q3 2025, an estimated $2.42M.
  • Fermata Advisors first reported a position in Innovator US Equity Ultra Buffer ETF January in Q1 2021 and held it in 13 quarters.
  • Fermata Advisors's Innovator US Equity Ultra Buffer ETF January position peaked at $21.3M in Q3 2024.
  • 96 funds tracked by Wall St. Rank held Innovator US Equity Ultra Buffer ETF January as of Q3 2025.

Based on Fermata Advisors's 13F filing for Q3 2025, filed 9 Oct 2025.